TG Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
TGTX Key Statistics
Stock Snapshot
TG Therapeutics(TGTX) stock is priced at $39.19, giving the company a market capitalization of 6B. It carries a P/E multiple of 13.66.
As of 2026-05-28, TG Therapeutics(TGTX) stock has fluctuated between $38.55 and $39.31. The current price stands at $39.19, placing the stock +1.7% above today's low and -0.3% off the high.
TG Therapeutics(TGTX) shares are trading with a volume of 310K, against a daily average of 1.48M.
During the past year, TG Therapeutics(TGTX) stock moved between $25.28 at its lowest and $44.65 at its peak.
During the past year, TG Therapeutics(TGTX) stock moved between $25.28 at its lowest and $44.65 at its peak.
TGTX News
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
TG Therapeutics (TGTX) announced topline results from the Phase 3 ENHANCE trial, a randomized, double-blind study evaluating a consolidated single infusion regi...
Analyst ratings
75%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.